ALTbasketball, Inc. Launches Both the "ALTbasketball Smaller Rim Concept" to be Promoted to the NBA as and the Development of Professional League w/ Lower Rims for Women
The 'ALTbasketball Smaller Rim Concept' is being promoted to the National Basketball Association (NBA), to support in entertainment and player/fan engagement considerations.
Additionally, ALTbasketball, Inc. is announcing the development of the company's new professional, national women's basketball league, featuring the ALTbasketball Smaller Rim Concept and addi lower than the traditional 10' in height.
The women's game being played on a 'lower rim' is on record as early as 2012, being requested by Geno Auriemma, the Winningest NCAA Women's basketball coach.
ALTbasketball, a Delaware corporation, with operations in Louisville, KY, is led by Founder, Nick Lopez, former youth boys and girls basketball coach and trainer.
ALTbasketball, Inc. is promoting the 'ALTbasketball Smaller Rim Concept' via website, social media and basketball events for the general public to review.
'ALTbasketball's national professional women's league is designed to be sustainable in itself… but actually it's only the start of the 'Growth and Sustainability Flywheel.' The league will be the driving force behind increasing the interest and demand in female youth basketball which will in turn demand significant infrastructure changes nationwide including new courts specific to the ALTbasketball women's game,' said Nick Lopez, Founder of ALTbasketball.
With the announcement of ALTbasketball, the company cites it now advances to 'Phase 1,' the 'Attention Phase' where concept is to be proven viable by sourcing the crowd and verifying support through testimonials and social sharing.
Once the fan demand is verified, ALTbasketball cites that sponsors will be onboarded, and the league will initiate in the next phase, identified as the 'Entertainment Phase' where players will be established.
In the Entertainment Phase, ALTbasketball will facilitate try-outs in multiple states, with a model inspired by the AND 1 Mixtape Tour. ALTbasketball promotes that they will be 'scouting, elevating, supporting and developing new stars of the game.'
'ALTbasketball is reverse engineered to give the fans what they want. The focus is not foremost on the player experience, but rather the fans and their specific interest. Fortunately, the economics suggest that where there is fan interest, money will flow. And where money flows, when a league is not restricted by legacy infrastructure, or bottlenecks of status quo thinking… it may be possible to scale, and scale big,' said Nick Lopez, Founder of ALTbasketball.
To learn more, Start Here at altbasketball.com or contact [email protected]
Source: ALTbasketball, Inc.
Bunyasaranand, Kimie. 'Geno Auriemma wants lower rim to improve women's basketball' *ESPN* October, 23, 2012, https://www.si.com/si-wire/2012/10/23/geno-auriemma-lower-rim-ncaa-womens-basketball
Wilco, Daniel. 'Women's college basketball coaches with the most wins in DI history' *NCAA* April, 10, 2025,
https://www.ncaa.com/news/basketball-women/article/2024-11-20/winningest-coaches-womens-college-basketball-history
Contact Information:
ALTbasketball, Inc.
Nick Lopez
(844) 737-1459
Contact via Email
altbasketball.com
Read the full story here: ALTbasketball, Inc. Launches Both the 'ALTbasketball Smaller Rim Concept' to be Promoted to the NBA as and the Development of Professional League w/ Lower Rims for Women
Press Release Distributed by PR.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Dolphins place Alexander Mattison on season-ending injured reserve, sign two veteran running backs
MIAMI GARDENS, Fla. (AP) — The Miami Dolphins placed Alexander Mattison on injured reserve Monday after the veteran running back suffered a season-ending neck injury in a preseason game against the Chicago Bears. Mattison left Sunday's game with a neck injury after being tackled on a 21-yard pass play and landing awkwardly on his head in the fourth quarter. Coach Mike McDaniel said afterward that Mattison had some soreness in his neck and shoulder. Mattison was taken to a hospital and had season-ending neck surgery, ESPN reported. The Dolphins signed Mattison to a one-year deal in March to bolster their running back room, and he had been a standout in training camp so far, showing his power-running skills and ability to break through for big runs. With Mattison out for the season, the Dolphins signed veteran running backs Mike Boone and Aaron Shampklin on Monday to compete for snaps behind starter De'Von Achane and second-year running back Jaylen Wright. Mattison's injury means rookie Ollie Gordon II is also in the mix for more snaps. Gordon had a promising performance in Sunday's 24-24 preseason tie against the Bears, finishing with eight carries for 33 yards and a touchdown, along with a 39-yard catch. Mattison spent the first five seasons of his career in Minnesota — he rushed for 2,370 yards with 4.1 yards per rush and 11 touchdowns. He had four TDs and 420 yards last season with Las Vegas. ___ AP NFL:
Yahoo
16 minutes ago
- Yahoo
Regeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) awarded the 13th annual Regeneron Prize for Creative Innovation to early-career biomedical researchers who displayed exceptional innovation. The winners for 2025 are Dr. Alissandra L. Hillis, a postdoctoral fellow at MIT, and Mr. Sreekar Mantena, a Harvard-MIT M.D.-Ph.D. candidate and Broad Institute nominee. Each received an institutional award of $5,000 and $50,000. Copyright: delcreations / 123RF Stock Photo Top U.S. research institutions nominate candidates for the Regeneron Prize to submit 'dream projects' in biomedicine. Dr. Hillis from Professor Matthew Vander Heiden's lab suggested new methods for researching endometriosis. Mr. Mantena, who works under Professor Soumya Raychaudhuri at Brigham and Women's Hospital, wants to investigate thymic decrease with age using single-cell genomics. Seven other finalists earned $5,000 each. The prize has given out close to $2 million since it was established in 2013. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)'s broader STEM programs have reached 3.25 million students worldwide since 2020. While we acknowledge the potential of REGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.
Yahoo
16 minutes ago
- Yahoo
US and China extend trade truce another 90 days, easing tension between world's largest economies
WASHINGTON (AP) — President Donald Trump extended a trade truce with China for another 90 days Monday, at least delaying once again a dangerous showdown between the world's two biggest economies. Trump posted on his Truth Social platform that he signed the executive order for the extension, and that 'all other elements of the Agreement will remain the same.' Beijing at the same time also announced the extension of the tariff pause via the official news agency Xinhua. The previous deadline was set to expire at 12:01 a.m. Tuesday. Had that happened the U.S. could have ratcheted up taxes on Chinese imports from an already high 30%, and Beijing could have responded by raising retaliatory levies on U.S. exports to China. The pause buys time for the two countries to work out some of their differences, perhaps clearing the way for a summit later this year between Trump and Chinese President Xi Jinping, and it has been welcomed by the U.S. companies doing business with China. Sean Stein, president of the U.S.-China Business Council, said the extension is 'critical' to give the two governments time to negotiate a trade agreement that U.S. businesses hope would improve their market access in China and provide the certainty needed for companies to make medium- and long-term plans. 'Securing an agreement on fentanyl that leads to a reduction in U.S. tariffs and a rollback of China's retaliatory measures is acutely needed to restart U.S. agriculture and energy exports,' Stein said. Reaching a pact with China remains unfinished business for Trump, who has already upended the global trading system by slapping double-digit taxes – tariffs – on almost every country on earth. The European Union, Japan and other trading partners agreed to lopsided trade deals with Trump, accepting once unthinkably U.S. high tariffs (15% on Japanese and EU imports, for instance) to ward off something worse. Trump's trade policies have turned the United States from one of the most open economies in the world into a protectionist fortress. The average U.S. tariff has gone from around 2.5% at the start of the year to 18.6%, highest since 1933, according to the Budget Lab at Yale University. But China tested the limits of a U.S. trade policy built around using tariffs as a cudgel to beat concessions out of trading partners. Beijing had a cudgel of its own: cutting off or slowing access to its rare earths minerals and magnets – used in everything from electric vehicles to jet engines. In June, the two countries reached an agreement to ease tensions. The United States said it would pull back export restrictions on computer chip technology and ethane, a feedstock in petrochemical production. And China agreed to make it easier for U.S. firms to get access to rare earths. 'The U.S. has realized it does not have the upper hand,'' said Claire Reade, senior counsel at Arnold & Porter and former assistant U.S. trade representative for China affairs. In May, the U.S. and China had averted an economic catastrophe by reducing massive tariffs they'd slapped on each other's products, which had reached as high as 145% against China and 125% against the U.S. Those triple-digit tariffs threatened to effectively end trade between the United States and China and caused a frightening sell-off in financial markets. In a May meeting in Geneva they agreed to back off and keep talking: America's tariffs went back down to a still-high 30% and China's to 10%. Having demonstrated their ability to hurt each other, they've been talking ever since. 'By overestimating the ability of steep tariffs to induce economic concessions from China, the Trump administration has not only underscored the limits of unilateral U.S. leverage, but also given Beijing grounds for believing that it can indefinitely enjoy the upper hand in subsequent talks with Washington by threatening to curtail rare earth exports,'' said Ali Wyne, a specialist in U.S.-China relations at the International Crisis Group. "The administration's desire for a trade détente stems from the self-inflicted consequences of its earlier hubris.' It's unclear whether Washington and Beijing can reach a grand bargain over America's biggest grievances. Among these are lax Chinese protection of intellectual property rights and Beijing's subsidies and other industrial policies that, the Americans say, give Chinese firms an unfair advantage in world markets and have contributed to a massive U.S. trade deficit with China of $262 billion last year. Reade doesn't expect much beyond limited agreements such as the Chinese saying they will buy more American soybeans and promising to do more to stop the flow of chemicals used to make fentanyl and to allow the continued flow of rare-earth magnets. But the tougher issues will likely linger, and 'the trade war will continue grinding ahead for years into the future,'' said Jeff Moon, a former U.S. diplomat and trade official who now runs the China Moon Strategies consultancy. ____ Associated Press Staff Writer Josh Boak contributed to this story. Paul Wiseman And Didi Tang, The Associated Press
